Lamictal effective in treating patients with partial seizures

Epilepsy :: Lamictal effective in treating patients with partial seizures

Data from two clinical trials presented at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended re-lease formulation of Lamictal? (lamotrigine) is effective as add-on treatment in patients with partial epilepsy with and without secondary generalization. Lamictal XR Extended-Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, new generation epilepsy treatment taken once-daily.

Data from the ARMOR study, an international, multi-center, randomized, double-blind, placebo-controlled trial, showed that the new once-daily, extended release formulation reduced partial seizures by 46 percent, while patients taking placebo experienced a reduction of 24 percent over the entire nineteen-week treatment period. The study also showed significant overall reduction in seizure frequency in both the escalation and maintenance treatment phases. In addition, the study showed that 42 percent of patients treated with Lamictal XR reduced their frequency of seizures by at least half by the end of the 19-week treatment period.

The second study, COMPASS, showed that patients could be switched from Lamictal? Immediate Release (IR) to Lamictal XR while maintaining comparable blood levels of lamotrigine.

?These data are important because they show that the extended release formulation of Lamictal reduces the frequency of seizures. The once daily dosing regimen may also provide a more convenient treatment option for patients,? said Dean Naritoku, M.D., Professor of Neurology and Pharmacology, Southern Illinois University, Springfield, IL. ?In addition, when compared to Lamictal immediate release, given twice a day, the new investigational formulation demonstrated fewer daily fluctuations in serum concentration and more stable blood levels over time.?




(Epilepsy :: Lamictal effective in treating patients with partial seizures published at SpiritIndia on Tuesday, May 8, 2007)

Epilepsy

Search more information on Epilepsy, Epilepsy books

Recently posted related articles on Epilepsy :

1. Epilepsy :: Reports of seizure frequency may be inaccurate in patients with focal epilepsy
2. Epilepsy :: Once-a-day epilepsy drug is effective for partial seizures
3. Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal
4. Epilepsy :: Research shows how genetic mutation causes epilepsy in infants
5. Epilepsy :: GSK's Lamictal extended-release tablets for epilepsy
6. Epilepsy :: Study of New Epilepsy Treatment Underway at URMC
7. Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
8. Epilepsy :: Ovation further advances development pipeline with new phase III epilepsy study
9. Epilepsy :: Experiencing auras? You may be a good candidate for epilepsy surgery
10. Epilepsy :: Miniature implanted devices could treat epilepsy, glaucoma

Most related articles:

- Epilepsy :: Lamictal effective in treating patients with partial seizures
- Epilepsy :: New data shows once a day LAMICTAL XR is effective in patients with partial epilepsy - 22.7
- Epilepsy :: GSK's Lamictal extended-release tablets for epilepsy - 18.4
- Epilepsy :: New drug shows promise for treating epileptic seizures - 15.6
- Epilepsy :: Once-a-day epilepsy drug is effective for partial seizures - 15.3
- Epilepsy :: Eslicarbazepine a new drug for epilepsy treatment - 14.8
- Epilepsy :: Repeated epilepsy seizures harmful - 12.7
- Epilepsy :: Reports of seizure frequency may be inaccurate in patients with focal epilepsy - 12.4
- Epilepsy :: New indication for Topamax for adults and children with epilepsy - 12.3
- Epilepsy :: Wake Forest University Baptist Medical Center To Test New Epilepsy Treatment - 11.8

Epilepsy - recent related articles/news stories:

- Sabril to treat spasms in infants and epileptic seizures approved in US
- Epilepsy drug valproate during pregnancy lowers child's IQ
- Epilepsy drug topiramate during pregnancy raises birth defects risk
- Oxcarbazepine doesn't help prevent migraine after all
- Suicidal thoughts and behaviours from epilepsy drugs, alerts Medsafe

»»   Wound :: Rapid healing with novel wound dressings
««   Influenza :: GSK supports WHO efforts to strengthen global pandemic preparedness plans

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com